National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 11) (No. PB 79 of 2013) (Cth)
PB 79 of 2013
National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No. 11)
National Health Act 1953
___________________________________________________________________________
I, Kim Bessell, Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.
Dated 27 November 2013
KIM BESSELL
Assistant Secretary
Pharmaceutical Access Branch
Principal Pharmacy Advisor
Pharmaceutical Benefits Division
Department of Health
___________________________________________________________________
1 Name of Instrument
(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2013 (No.11).
(2)This Instrument may also be cited as PB 79 of 2013.
2 Commencement
This Instrument commences on 1 December 2013.
3 Amendments to PB 79 of 2011
Schedule 1 amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).
Schedule 1 Amendments
Schedule 1 Part 1, entry for Ifosfamide:
omit:
Ifosfamide Powder for I.V. injection 1 g in single dose vial Injection Holoxan BX MP C1325 C1327 D Powder for I.V. injection 2 g in single dose vial Injection Holoxan BX MP C1325 C1327 D
insert:
Ifosfamide Powder for I.V. injection 1 g Injection Holoxan BX MP D Powder for I.V. injection 2 g Injection Holoxan BX MP D
Schedule 4, after the entry for Idarubicin:
omit:
Ifosfamide C1325 Relapsed or refractory germ cell tumours following first‑line chemotherapy C1327 Relapsed or refractory sarcomas following first‑line chemotherapy
0
0
0